Skip to main content

Telemedicine Medicines in India: List O, A, B, Prohibitions and Amendments

Remote prescribing in India requires checking the current medicine list, consultation mode, first-or-follow-up status and whether the clinician has enough information. Read the 2020 telemedicine guidelines with subsequent medicine-list amendments. A video call, old prescription or “repeat patient” label does not automatically make a medicine or a remote treatment decision appropriate.

By Bractis · Updated · 9 min read

Registered medical practitioners, teleconsultation coordinators and clinic software buyers designing remote prescription and refill workflows.

Check the applicable document and its amendments before building a drug list

Search results can mix the March 2020 guidelines, later medicine-list changes, professional commentary and the 2023 conduct regulations placed in abeyance. A clinic needs a dated source trail showing which rules informed its workflow. The newest-looking PDF title is not a sufficient basis for a prescribing policy.

Use the 2020 telemedicine framework together with relevant subsequent notifications and applicable drug law. NMC’s regulations index identifies the August 2023 abeyance notification. Check for later changes before operational use, rather than treating an old saved table as a permanently current permission list.

One important amendment is the MCI notice dated 11 April 2020, which added phenobarbitone, clobazam and clonazepam to List A for first and follow-up consultations. This named change is why a blanket statement about every psychiatric medicine or every medicine in a broad class can be misleading.

The amendment does not supply a treatment regimen or extend by analogy to other drugs. Keep the exact instrument and scope with the medicine-list record. Where classification or the interaction of rules is uncertain, obtain competent clarification before the affected prescribing decision.

Source: NMC regulations index: 2023 conduct regulations held in abeyance

Source: MCI: Medicine-list modification dated 11 April 2020

Use the categories as one check within a larger clinical decision

The original guidelines distinguish List O, List A, List B and a prohibited category. Their baseline restriction covers Schedule X medicines and narcotic or psychotropic substances under the NDPS framework, read with specific amendments. “List X” is not a substitute name for these separate concepts.

The summary below is intentionally limited. It does not reproduce a comprehensive medicine catalogue, determine the status of a particular formulation or remove the need for adequate assessment. Check the current source for the exact medicine and encounter.

On a narrow screen, scroll the table horizontally to read all columns.

Telemedicine medicine categories: a starting point for verification
CategoryFramework distinctionClinic review question
List OMay be considered through any consultation modeIs the particular medicine in the current list and appropriate for this patient?
List AFirst consultation by video; refill provisions for follow-upDoes the encounter meet the applicable conditions and any specific amendment?
List BAdditional treatment in qualifying follow-up for the same condition after in-person careIs the prior care and current follow-up basis established?
Prohibited categoryNot remotely prescribable under the applicable restrictionHave exact classification and any specific later amendment been checked?

Source: MoHFW eSanjeevani: Telemedicine Practice Guidelines, 2020

Establish follow-up eligibility instead of clicking “repeat”

A patient known to the clinic is not necessarily a follow-up for the same condition. A new complaint, a material change in symptoms, an unclear previous plan or a different treating relationship may require a different assessment. The appointment label should not decide the legal or clinical status of the encounter.

Retrieve the prior encounter and the actual treatment instructions. Record which condition is being reviewed, the relevant dates and clinician relationship, and check the guideline’s follow-up conditions. An image of an old medicine strip is useful information, but it does not establish every element of a qualifying follow-up.

Ask what has changed since the previous assessment: the patient’s account, treatment actually taken, new information and any barriers to care. Keep those answers in the clinical record rather than relying solely on a refill button that repeats the old order.

If the conditions are not established, do not manufacture them by backdating a visit or merging an unrelated consultation. The clinician should decide what assessment or referral is needed and explain the practical next step. Administrative convenience should not transform a new problem into a routine refill.

Clinical sufficiency is a separate decision from medicine eligibility

Even when a medicine passes a list check, the available consultation may be inadequate for a safe decision. A poor connection, uncertain identity, incomplete history or need for examination can make remote management unsuitable. The clinician should record the material limitation and the resulting plan.

A completed video connection proves that a call occurred; it does not prove that all relevant findings were assessed. Avoid documentation that automatically marks an examination normal because the visit mode was video. Record what could actually be observed and what could not.

Similarly, a medicine being excluded from remote prescribing does not mean that the patient should be abandoned or told to stop existing treatment abruptly. Arrange appropriate assessment and continuity through the treating professional. A coordinator should not suggest a substitute medicine to bypass a restriction.

Keep urgent-care routing usable. If the presentation needs prompt in-person assessment, the response should explain the relevant destination and urgency selected by the clinician. A promise to offer a later video slot may be an inadequate response to the actual situation.

Handle refill messages without allowing reception to prescribe

Define what staff can collect before review: patient identity, contact route, prior document reference, medicine details as reported and the reason for the request. Collection is not authorisation. The staff script should avoid saying a refill is approved before a clinician reviews it.

The request may arrive from a caregiver or a pharmacy rather than the patient. Establish the relevant authority and communication arrangement. Do not assume that a forward of an old prescription gives the sender permission to receive every new clinical detail.

Route an uncertain medicine classification or missing prior record to the responsible professional. A well-designed queue should show why the request needs review and who owns it. Repeatedly passing the same message between reception and a doctor without an accountable next step leaves the patient in limbo.

Record the outcome in terms the patient can use: prescription issued after review, further information requested, in-person assessment arranged or another clinician-authorised plan. “Rejected” alone says little about what the patient should do or why the request could not be completed remotely.

Keep a decision record that explains the route taken

The record should let another authorised clinician understand the basis for the remote decision. It need not contain an essay about every law, but it should preserve material facts about the consultation, previous care, assessment limits and the resulting plan.

Where a specific amendment or classification question matters, retain the relevant reference in the clinic’s controlled policy or product record. Do not paste a legal paragraph into every patient note as a replacement for the clinician’s reasoning.

The following outline is an original workflow aid. It is not a statutory form, a remote-prescribing permission or a clinical protocol.

Test stale lists, failed video and uncertain follow-up during procurement

A vendor may demonstrate a smooth remote visit with a preselected medicine and a complete patient history. Add cases that expose decision boundaries: an unverified prior prescription, a changed complaint, a failed video session and an exact drug whose classification needs review.

Ask who maintains medicine eligibility data, which sources they use and how an update reaches the clinic. A hard-coded list can become stale; an automatic update can also be wrong or insufficiently scoped. The clinic needs visibility into changes that affect prescribing decisions.

Inspect overrides and audit history. If an authorised exception process exists, it should preserve the reason and reviewer rather than making a restriction disappear without trace. Software should not encourage a clinician to select an inaccurate visit type to unlock an order.

Finally, test the patient handover. A correctly blocked order is only one part of the workflow; the patient still needs a clinician-approved next step. Use fictional data and a mock recipient to evaluate the complete process without generating real prescriptions or contacting patients.

Worked example: “known patient” hides a new clinical problem

A fictional Indore clinic receives a refill request from a patient previously seen for one condition. During the message exchange, a new concern emerges, and the previous prescription is not available in the record. The coordinator leaves the request for clinician review rather than marking it as a routine follow-up. The doctor decides what further assessment is needed and gives a clear next step. The example turns on the encounter’s actual basis; neither a saved contact nor a past clinic visit settles it.

Telemedicine Medicine Decision Record

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Source version
Identify the guideline, specific amendments and product classification sources used by the clinic. Who checks for changes?
Follow-up basis
For a fictional repeat request, retrieve the prior encounter and state why it does or does not meet the applicable follow-up conditions.
Assessment limits
Simulate an interrupted call or missing history. Can the clinician preserve the limitation and arrange another care route?
Patient handover
Trace a request that cannot be completed remotely. Does the patient receive an actionable clinician-approved plan?

Questions doctors ask

Is “List X” the name of India’s prohibited telemedicine list?

Use the terminology in the applicable guideline and drug law. Schedule X is a drug-schedule concept; the telemedicine framework uses its own categories and a prohibited category. Confusing these labels can hide the need to check specific amendments and product classification.

Why should a clinic avoid a blanket statement about all psychiatric medicines?

The official April 2020 notice made a named medicine-list modification. A broad clinical class is therefore an unreliable shortcut. Review the exact medicine and current instruments instead of extending either a permission or a prohibition to every related product.

Does a video consultation automatically make prescribing appropriate?

No. The clinician still needs adequate information and must assess the patient, the encounter conditions and the exact medicine. A functioning camera cannot resolve missing history, an examination limitation or an applicable prescribing restriction.

Is an old prescription enough to approve a remote refill?

It is evidence to review, not automatic authorisation. Establish the prior care, current treatment, reason for the request and applicable follow-up conditions. A new concern or uncertain record may require a different assessment and plan.

What should reception do when a refill cannot be completed remotely?

Route the request to the responsible clinician, preserve the relevant facts and communicate the authorised next step. Do not recommend a substitute, promise supply or tell the patient to stop treatment solely because a software rule blocked the request.

Sources and scope

Updated on . Workflow explanation for qualified practitioners. No exhaustive prohibited list, dose or treatment recommendation is supplied. Verify current instruments and obtain appropriate clinical or regulatory advice for the exact medicine and situation. No independent clinical or legal review is claimed.

Try the workflow
with Bractis.

Ask Bractis to handle fictional remote requests with missing prior records, a failed video session and a classification question. Inspect the decision history and the patient’s next-step instructions, not only whether an order button is enabled.

Request a clinic demo